Egypt Cardiac Monitoring and Cardiac Rhythm Management Devices Market to be Dominated by the Hospitals & Clinics Segment by 2028
Growing technological advancement in cardiac monitoring
devices is expected to drive the Egypt Cardiac Monitoring and Cardiac Rhythm
Management Devices market in the forecast period 2024-2028.
According to TechSci Research report, “Egypt Cardiac Monitoring and Cardiac
Rhythm Market - By Region, Competition, Forecast and
Opportunities, 2018-2028,
the Egypt Cardiac Monitoring and Cardiac
Rhythm Management Devices market is anticipated to grow at a steady rate in the
forecast period 2024-2028. The market for cardiac monitoring and cardiac
rhythm management devices is anticipated to be driven by the growing cases of
cardiovascular diseases, technological advancement in cardiac monitoring and
rhythm management devices, along with the growing awareness among the
population about cardiovascular health in the country. Also, the rising government
support and availability of government and reimbursement plan, along with updated
government’s schemes regarding cardiac health maintenance among the population are
boosting the demand for cardiac monitoring and cardiac rhythm management
devices market.
The market is
primarily driven by an increasing prevalence of cardiovascular diseases and
rising aging population. The high incidence of obesity, hypertension, and
diabetes also contributes to the demand for cardiac rhythm management devices
in the country. Pacemakers are
the most commonly used CRMDs in Egypt. These devices help regulate heart rhythm
by sending electrical impulses to the heart, ensuring proper heart function.
Pacemakers are used to treat patients with bradycardia (slow heart rate) and
heart block.
Implantable
cardioverter-defibrillators (ICDs) are used to treat patients with
life-threatening arrhythmias, such as ventricular fibrillation and ventricular
tachycardia. These devices monitor heart's rhythm and deliver an electrical
shock to restore normal heart rhythm according to the requirement. Cardiac
resynchronization therapy (CRT) devices are used to treat heart failure
patients with left ventricular dysfunction. These devices send electrical
impulses to both ventricles to synchronize heart contractions, thereby
improving cardiac output and reducing heart failure symptoms. This aspect is further
contributing to the growing demand for cardiac monitoring and cardiac rhythm
management devices market in the forecast period.
The growing sedentary
lifestyle and lack of exercise among the population are among the major causes
for the increasing risk of cardiac diseases. A sedentary lifestyle and a diet
high in fats, sugars, and salts, have become increasingly common, contributing
to the high prevalence of obesity and other risk factors for cardiovascular
diseases.
Technological advancements
have led to the development of more advanced and efficient cardiac monitoring
and cardiac rhythm management devices. For instance, the use of wireless
technologies and cloud-based data storage has enabled remote monitoring of
patients, providing real-time data to healthcare providers, and allowing for
more personalized and effective treatment. The most popular cardiovascular
rhythm management devices in Egypt are pacemakers and implanted
cardioverter-defibrillators (ICDs). These devices assist in controlling cardiac
rhythm, ensuring the heart's efficient functioning. The country's expanding use
of these devices is anticipated to fuel cardiac monitoring and cardiac rhythm
management devices market expansion. Also, rising healthcare expenditure is
driving the cardiac monitoring and cardiac rhythm management devices industry.
Governments and healthcare providers are investing more in healthcare
infrastructure, including the adoption of new technologies, to improve patient
outcomes and reduce the burden of cardiovascular diseases on healthcare
systems.
Furthermore,
the COVID-19 pandemic has accelerated the adoption of remote patient monitoring
and telemedicine, leading to an increased demand for cardiac monitoring and
cardiac rhythm management devices. It has also highlighted the importance of
early detection and management of cardiovascular diseases, further driving the
demand for cardiac monitoring & cardiac rhythm management devices market
devices.
However, the high
cost of these devices continues to be a major obstacle, preventing their
widespread acceptance in the nation. Additionally, the government's initiatives
to control medical device cost and encourage domestic manufacturing are
anticipated to maintain the cost and availability for cardiac devices in the
country, thus expanding the growth of cardiac monitoring and cardiac rhythm
management devices market in the forecast period.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Egypt Cardiac Monitoring and Cardiac Rhythm Management Devices Market.”
Based
on end users, the market is segmented into hospitals & clinics, cardiac
care centers, ambulatory surgery centers, and others. The hospitals &
clinics segment dominated the market in 2022 and is expected to hold the
highest market share in the forecast period. This is attributed to the high
admission in the hospitals & clinics for cardiac surgeries and the large
number of cardiac devices and cardiac monitoring devices availability in the
hospitals & clinics. Additionally, the availability of government
subsidiaries and reimbursement facilities are easily available in the hospitals
& clinics, making them more prominent places for availability of cardiac
devices for the public.
Based on type,
the market is segmented into cardiac monitoring devices and cardiac rhythm
management devices. The cardiac rhythm management device segment dominated in
2022 and is expected to hold the highest share in the forecast period. This is
due to the increased demand for cardiac rhythm management devices including pacemakers
and implantable cardioverter defibrillators.
Major companies operating in the Egypt
cardiac monitoring and cardiac rhythm management devices market are:
- Medistim (Promed-Distributor)
- Medtronic, Inc.
- Canadian Cardiac Care
- Boston Scientific Corporation
- St. Jude Medical, Inc.
- Abbott Laboratories, B
- BIOTRONIK SE & Co.
KG
- Terumo Corporation
- Biosense Webster Inc.
- GE Healthcare
Download Free Sample Report
Customers can also request for 10% free
customization on this report.
“The cardiac rhythm
management devices such as pacemakers and defibrillators are high in demand in
the country and are expected to dominate the Egypt cardiac monitoring and
cardiac rhythm management devices market. This growth is attributed to
increasing cases of cardiovascular diseases and rising conditions such as
abnormal heartbeat and arrhythmias in Egypt. Besides, technological advancements provide use
of sophisticated algorithms and sensors in tracking cardiovascular conditions
and provide personalized insights into an individual's heart status which
further seems to better management of heart health in the country. Also, increasing
awareness among the population for maintaining their health is anticipated to
support the cardiac health monitoring and cardiac health management growth in
the country” said Mr. Karan Chechi, Research Director with TechSci Research, a
research based global management consulting firm.
“Egypt Cardiac Monitoring
& Cardiac Rhythm Management Devices Market, By Type (Cardiac Monitoring
Devices, Cardiac Rhythm Management Device), By End User (Hospitals &
Clinics, Cardiac Care Centers, Ambulatory Surgery Centers, Others), By Region,
Competition Forecast & Opportunities, 2028F”, has evaluated the future
growth potential of Egypt cardiac monitoring and cardiac rhythm management
devices market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Egypt cardiac monitoring
and cardiac rhythm management devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com